about
Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signallingRNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1Polymerized laminin-332 matrix supports rapid and tight adhesion of keratinocytes, suppressing cell migrationA keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence.RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cellsColorectal cancer and basement membranes: clinicopathological correlations.Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.The basement membrane matrix in malignancy.Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progressionCo-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture.Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration.Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.Mechanobiology of tumor invasion: engineering meets oncology.Surgical margins in head and neck squamous cell carcinoma: Effect of heat artifact on immunohistochemistry as a future tool for assessment.Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China.Identification of a novel family of laminin N-terminal alternate splice isoforms: structural and functional characterization.Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors.Liposomal nanomedicine for breast cancer therapy.Meeting the biologic challenge of colorectal metastases.Components of cell-matrix linkage as potential new markers for prostate cancer.Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction.Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasisModulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5).A recurrence model for laryngeal cancer based on SVM and gene function clustering.Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.The cAMP-Epac-Rap1 pathway regulates cell spreading and cell adhesion to laminin-5 through the alpha3beta1 integrin but not the alpha6beta4 integrin.Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding.Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin.Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.A case of antiepiligrin cicatricial pemphigoid with nephrotic syndrome.Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology.
P2860
Q24541434-0177022D-DA50-4354-A156-4FE2276998A2Q24647775-F8AC677D-92E0-4D54-93B7-0C7C6817BDEAQ27304390-54F39A82-FB5F-4814-B1C2-AC84F1FABA38Q30478118-AE7C24E3-7D09-453E-AB41-0086A981BF69Q33946423-A22F3917-C294-4041-90F1-C1EF6BAF7E03Q34968207-5FD72591-7912-4F2E-96A0-006878FCCAFEQ35083735-0489ED22-1985-40CD-B55E-01FD3041C658Q35170435-DAD98FD4-2D32-45B8-8C08-64BCE39A687FQ35421768-26A92BB7-C982-4493-9515-5F56F752FF62Q35791738-D78993CB-51DE-41A1-97B4-0992E324D17EQ35843445-3B35D3CC-DF2C-43F5-8C40-C3C8C0430E40Q35868532-3E490DAF-E2C3-4BFA-928B-F7109F61590CQ35877893-CB5AD292-4A0D-4973-9AFC-4FE13A427250Q35979153-60721B89-9875-4BE4-BB53-A9ACA6C1E8C7Q37312245-9047DA8F-CD41-4F25-98BB-555502423C8FQ37467630-C78E32D5-0D09-4484-9258-FA8DCCFB7F9BQ37821837-C79E1AFD-CB49-4F22-B700-DF4BF016E08FQ37939968-B3151AC2-22C2-42BE-9879-391E1AC962F9Q38051068-A7E5A217-7DBE-48DC-8D95-1BCAA4765729Q38161339-E2995C3B-66D2-45C5-A1F8-37764C17392DQ38287144-92E0EFF6-BDA6-4C17-84E3-7B397E0625B3Q38622731-B6732C28-07AD-4F59-9A10-2C2F252E78E0Q39051674-49A640DA-6495-420F-A6A5-9A5FE1AA902BQ39220488-60AD1BBE-FF12-4874-8663-E394B9F537B4Q39724927-6ADFECED-1DB6-43B4-BB39-D0B36007EC87Q39739693-5EACC3B8-D659-4CC4-B877-BB36355AA014Q40235611-495CAC67-470A-4792-B878-618862E5BFC7Q40526979-BFFD47EC-1433-46E6-B9E2-202DD095370DQ40617498-9AE902AB-A6F4-4AD2-A2E9-CA21EAA68E1BQ42086943-84AA822D-451B-43F4-BCC1-B966478861B2Q42485449-0D7A6324-49C4-4EF4-92FC-2B70E8CF6D63Q44929219-40FF4D48-AB57-4ABB-ABED-C6FA73F835EBQ46433336-573B34B6-DFC1-4677-8D5E-66834CCE0A08Q47235743-737CE7C7-3A57-455A-A49F-0FC6F42C4834Q47708810-E92C0019-F67C-44EB-8AD1-00E3D1B930A8
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Laminin-5 in the progression of carcinomas.
@ast
Laminin-5 in the progression of carcinomas.
@en
Laminin-5 in the progression of carcinomas.
@nl
type
label
Laminin-5 in the progression of carcinomas.
@ast
Laminin-5 in the progression of carcinomas.
@en
Laminin-5 in the progression of carcinomas.
@nl
prefLabel
Laminin-5 in the progression of carcinomas.
@ast
Laminin-5 in the progression of carcinomas.
@en
Laminin-5 in the progression of carcinomas.
@nl
P2860
P356
P1476
Laminin-5 in the progression of carcinomas.
@en
P2093
P2860
P304
P356
10.1002/IJC.1539
P577
2001-12-01T00:00:00Z